IP Verse

Polynucleotide Enrichment Using Crispr-Cas Systems - EP3172321

The patent EP3172321 was granted to Illumina on Jan 4, 2023. The application was originally filed on Jul 20, 2015 under application number EP15753229A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3172321

ILLUMINA
Application Number
EP15753229A
Filing Date
Jul 20, 2015
Status
Patent Maintained As Amended
Dec 2, 2022
Grant Date
Jan 4, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KILGERApr 1, 2020ADMISSIBLE

Patent Citations (39) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2011US57111-
DESCRIPTIONUS2005191698
DESCRIPTIONUS2008108082
DESCRIPTIONUS2009026082
DESCRIPTIONUS2009127589
DESCRIPTIONUS2010120098
DESCRIPTIONUS2010137143
DESCRIPTIONUS2010282617
DESCRIPTIONUS4883750
DESCRIPTIONUS5034506
DESCRIPTIONUS5432272
DESCRIPTIONUS5476930
DESCRIPTIONUS5593826
DESCRIPTIONUS5871921
DESCRIPTIONUS6210891
DESCRIPTIONUS6258568
DESCRIPTIONUS6274320
DESCRIPTIONUS7001792
DESCRIPTIONUS7057026
DESCRIPTIONUS7211414
DESCRIPTIONUS7244559
DESCRIPTIONUS7315019
DESCRIPTIONUS7329492
DESCRIPTIONUS7405281
DESCRIPTIONUS7595883
DESCRIPTIONWO2004018497
DESCRIPTIONWO2007123744
DESCRIPTIONWO9106678
DESCRIPTIONWO9523875
INTERNATIONAL-SEARCH-REPORTUS2014038241
INTERNATIONAL-SEARCH-REPORTUS2014356867
INTERNATIONAL-SEARCH-REPORTUS2014357523
INTERNATIONAL-SEARCH-REPORTWO2011053987
INTERNATIONAL-SEARCH-REPORTWO2014125668
INTERNATIONAL-SEARCH-REPORTWO2015075056
OPPOSITIONUS2002187508
OPPOSITIONUS2014127752
OPPOSITIONUS2014356867
OPPOSITIONWO2015075056

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Caryn R. Hale et al, "Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex", GENES AND DEVELOPMENT., COLD SPRING HARBOR LABORATORY PRESS, PLAINVIEW, NY., US, US, (20141101), vol. 28, no. 21, pages 2432 - 2443-
OPPOSITION- F. Ann Ran et al, "Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity", CELL, (20130901), vol. 154, no. 6, pages 1380 - 1389-
OPPOSITION- Nicholas Luzzietti et al, "Nicking enzyme-based internal labeling of DNA at multiple loci", Nature Protocols, Nature Publishing Group, GB, vol. 7, no. 4, pages 643 - 653-
OPPOSITION- F. Ann Ran, Patrick d. Hsu, Chie-Yu Lin, Jonathan s. Gootenberg, Silvana Konermann, Alexandro E. Trevino, David a. Scott, Azusa Inoue, Shogo Matoba, Yi Zhang, Feng Zhang, "Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity", CELL, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20130901), vol. 154, no. 6, doi:10.1016/j.cell.2013.08.021, ISSN 0092-8674, pages 1380 - 1389, XP055299681
OPPOSITION- Nicholas Luzzietti, Sabine Knappe, Isabel Richter, Ralf Seidel, "Nicking enzyme-based internal labeling of DNA at multiple loci", Nature Protocols, Nature Publishing Group, GB, GB, vol. 7, no. 4, doi:10.1038/nprot.2012.008, ISSN 1754-2189, pages 643 - 653, XP055417318
OPPOSITION- Caryn R. Hale, Alexis Cocozaki, Hong Li, Rebecca M. Terns, Michael P. Terns, "Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex", GENES AND DEVELOPMENT., COLD SPRING HARBOR LABORATORY PRESS, PLAINVIEW, NY., US, US, (20141101), vol. 28, no. 21, doi:10.1101/gad.250712.114, ISSN 0890-9369, pages 2432 - 2443, XP055247605
OPPOSITION- JINEK, Structures of Cas9 Endonuleases Reveal RNA-Mediated Conformational Activation, (20140314), XP055149157

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents